Lawmakers, Generic Industry Push for More Legislative Support as Study Shows Copycat Drugs Saved U.S. $1 Trillion

A A
Generic drugs have saved the U.S. more than $1 trillion over the past decade, a figure that well exceeds predictions from when the Hatch-Waxman Act was enacted in 1984, according to a new study.

To View This Article:

Login

Subscribe To Drug Industry Daily